FDA authorizes a second antiviral to treat COVID-19, a Merck pill that can be taken at home: Updates
A day after authorizing the first antiviral pill to treat COVID-19, the FDA on Thursday authorized a second: Merck's molnupiravir. Latest news.
FDA authorizes a second antiviral to treat COVID-19, a Merck pill that can be taken at home: Updates
Delawareonline
0 shares
1 views
You might like
Related news coverage
Pfizer antiviral pill could be risky with other widely used medications
PIX 11
The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the..
Advertisement
More coverage
FDA authorizes Merck's at-home antiviral COVID-19 pill
Jerusalem Post
Merck's drug molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30%.
-
The FDA has authorized Merck's COVID pill for home use — the second in two days
NPR
-
US adds Merck pill as 2nd easy-to-use drug against COVID-19
SeattlePI.com
-
Alert: Regulators authorize second COVID-19 pill for US patients, a Merck drug that can be taken at home
SeattlePI.com
-
US authorizes Merck’s at-home antiviral COVID-19 pill
Indian Express